Search
for
Sort by
Research 91–120 of 1000+
- 5‐α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population‐based cohort study
- Resolution of experimental malaria-associated acute respiratory distress syndrome is Alox12 independent and shows residual inflammation
- The RpoS Gatekeeper in Borrelia burgdorferi: An Invariant Regulatory Scheme That Promotes Spirochete Persistence in Reservoir Hosts and Niche Diversity
- Transposon control as a checkpoint for tissue regeneration
- Pilomatricoma in Syndromic Contexts: A Literature Review and a Report of a Case in Apert Syndrome
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Stimulation of the Follicular Bulge LGR5+ and LGR6+ Stem Cells with the Gut-Derived Human Alpha Defensin 5 Results in Decreased Bacterial Presence, Enhanced Wound Healing, and Hair Growth from Tissues Devoid of Adnexal Structures
- Interactions of the Vitamin D Receptor with the Corepressor Hairless
- Alopecia Areata Increases the Risk of Stroke: a 3-year Follow-Up Study
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Women with alopecia exhibit a higher risk for thyroid cancer: A nationwide cohort study
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- Bladder cancer survival in men using 5-alpha-reductase inhibitors
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study
- Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study
- Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
- The Polycystic Ovary Syndrome Evolutionary Paradox: a Genome-Wide Association Studies–Based, in silico, Evolutionary Explanation
- Trichoscopic findings in alopecia areata and their relation to disease activity, severity and clinical subtype in Turkish patients
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study
- High prevalence of poly cystic ovary syndrome among young Saudi medical students: an observational cross-sectional study
- Genetic links between atopy, allergy, and alopecia areata: insights from a Mendelian randomization study
- Indian Gooseberry (<i>Emblica officinalis</i>Gaertn.)
- Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study
- 883 Hair follicle bulb developed as 3D scaffold free microtissue
- 643 Male pattern baldness and risk of incident skin cancer in a cohort of men
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- MicroRNA in skin diseases